We
recognized the effectiveness of our pulsed magnetic system on
Fibromyalgia back in 2001. We documented results in this area of
research predating all published research. Our novel nighttime regimen is particularly effective.
Pulsed electromagnetic field (PEMF) therapy has proven effective on pain for 3 decades particularly in Eastern European research. Pulsed electromagnetic fields (PEMF) highly effective in a diverse range of therapeutic applications with no side-effects or adverse reactions. Got pain?...PEMF is probably the answer to your prayers.
If
you've got fibromyalgia pain (or migraine headaches), PEMF is
the answer to your prayers and we have rarely seen it fail. Pulsed
electromagnetic fields (PEMF) and repetitive transcranial magnetic
stimulation (rTMS) for fibromyalgia has not been well researched in the
peer-reviewed journals. You will only find a few published references
beginning in April 2006.
Frequency specificity in pulsed electromagnetic field (PEMF) therapy is currently being investigated in the West after Eastern European research found particular frequencies highly effective more than 3 decades ago.
EarthPulse™ is modeled after Eastern Europe's most effective and well tested frequencies and wave-forms. It is highly adaptable system that is primarily designed for nighttime use. If it doesn't exceed your expectations (for any purpose), just return it for a full refund (less shipping charges).
The use of pulsed electromagnetic field therapy is relatively new protocol for pain in the West, but over the last 3 decades has proven to be side-effect free and at least somewhat effective based upon the studies which rarely utilize the most effective protocols. Rarely do peer-reviewed PEMF studies prove less effective than placebo;...when they do, frequency, amplitude and wave-form shape are questionable.
See
also our Migraine Bibliography, Pain bibliography.
Pain Res Manag. 2007 Winter;12(4):249-58.
A
randomized, double-blind, placebo-controlled clinical trial using a
low-frequency magnetic field in the treatment of musculoskeletal
chronic pain.
Thomas AW, Graham K, Prato FS, McKay J, Forster PM, Moulin DE, Chari S.
Brain. 2007 Oct;130(Pt 10):2661-70. Epub 2007 Sep 14. Links
Effects
of unilateral repetitive transcranial magnetic stimulation of the motor
cortex on chronic widespread pain in fibromyalgia.
Passard A, Attal N, Benadhira R, Brasseur L, Saba G, Sichere P, Perrot S, Januel D, Bouhassira D.
INSERM U-792, Boulogne-Billancourt F-92100 France.
Non-invasive unilateral repetitive transcranial magnetic stimulation
(rTMS) of the motor cortex induces analgesic effects in focal chronic
pain syndromes, probably by modifying central pain modulatory systems.
Neuroimaging studies have shown bilateral activation of a large number
of structures, including some of those involved in pain processing,
suggesting that such stimulation may induce generalized analgesic
effects. We also assessed the effects of rTMS on the pressure pain
threshold at tender points ipsi- and contralateral to
stimulation. Active rTMS significantly reduced pain and improved
several aspects of quality of life (including fatigue, morning
tiredness, general activity, walking and sleep) for up to 2 weeks after
treatment had ended. The analgesic effects were observed from the fifth
stimulation onwards and were not related to changes in mood or anxiety.
The effects of rTMS were more long-lasting for affective than for
sensory pain, suggesting differential effects on brain structures
involved in pain perception. Only few minor and transient side effects
were reported during the stimulation period. Our data indicate that
unilateral rTMS of the motor cortex induces a
long-lasting decrease in chronic widespread pain and may therefore
constitute an effective alternative analgesic treatment for
fibromyalgia.
Pain.
2006 May;122(1-2):22-7. Epub 2006 Feb 21.
Comment in: * Pain. 2006 May;122(1-2):11-3.
Reduction
of intractable deafferentation pain by navigation-guided repetitive transcranial
magnetic stimulation of the primary motor cortex. Hirayama A, Saitoh Y,
Kishima H, Shimokawa T, Oshino S, Hirata M, Kato A, Yoshimine T. Department
of Neurosurgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka,
Suita, Osaka 565-0871, Japan. The precentral gyrus (M1) (TOP
OF THE HEAD) is a representative target for electrical stimulation therapy
of pain. To date, few researchers have investigated whether pain relief is possible
by stimulation of cortical areas other than M1. According to recent reports,
repetitive transcranial magnetic stimulation (rTMS) can provide an effect similar
to that of electrical stimulation. With this in mind, we therefore examined
several cortical areas as stimulation targets using a navigation-guided rTMS
and compared the effects of the different targets on pain. Twenty patients with
intractable deafferentation pain received rTMS of M1, the postcentral gyrus
(S1), premotor area (preM), and supplementary motor area (SMA). Each target
was stimulated with ten trains of 10-s 5-Hz TMS pulses, with 50-s intervals
in between trains. Intensities were adjusted to 90% of resting motor thresholds.
Thus, a total of 500 stimuli were applied. Sham stimulations were undertaken
at random. The effect of rTMS on pain was rated by patients using a visual analogue
scale (VAS) and the short form of the McGill Pain Questionnaire (SF-MPQ). Ten
of the 20 patients (50%) indicated that stimulation of M1, but not other areas,
provided significant and beneficial pain relief (p<0.01). Results indicated
a statistically significant effect lasting for 3 hours after the stimulation
of M1 (p<0.05). Stimulation of other targets was not effective. The M1 was
the sole target for treating intractable pain with rTMS, in spite of the fact
that M1, S1, preM, and SMA are located adjacently.
Pain Res Manag. 2006 Summer;11(2):85-90.
Exposure
to a specific pulsed low-frequency magnetic field: a double-blind placebo-controlled
study of effects on pain ratings in rheumatoid arthritis and fibromyalgia patients.
Lawson Health Research Institute, St. Joseph's Health Care, London, Ontario
N6A 4V2. BACKGROUND: Specific pulsed electromagnetic fields (PEMFs) have been
shown to induce analgesia (antinociception) in rodents and healthy human volunteers.
OBJECTIVE: The effect of specific PEMF exposure on pain and anxiety ratings
was investigated in two patient populations. DESIGN: A double-blind, randomized,
placebo-controlled parallel design was used. METHOD: The present study investigated
the effects of an acute 30 min magnetic field exposure. CONCLUSION: These findings
provide some initial support for the use of PEMF exposure in reducing pain in
chronic pain populations and warrants continued investigation into the use of
PEMF exposure for short-term pain relief.
Pain.2006 Apr;121(3):276-80. Epub 2006 Feb 21.
Electroconvulsive
therapy improves severe pain associated with fibromyalgia. Usui C, Doi N,
Nishioka M, Komatsu H, Yamamoto R, Ohkubo T, Ishizuka T, Shibata N, Hatta K,
Miyazaki H, Nishioka K, Arai H. Department of Psychiatry, Juntendo University
School of Medicine, Tokyo, Japan. The pathophysiology of fibromyalgia remains
unknown. Several reports have recently suggested the novel concept that fibromyalgia
is due to the central nervous system becoming hyper-responsive to a peripheral
stimulus. The effect of electroconvulsive therapy (ECT) as pain remedication
in cases of fibromyalgia without major depressive disorder was studied in a
prospective trial lasting three months. Our study clearly demonstrated that
pain was significantly less severe after ECT, as indicated by the VAS scale
for pain and the evaluation of TPs. A further notable observation was that thalamic
blood flow was also improved. We conclude that a course of ECT produced notable
improvements in both intractable severe pain associated with fibromyalgia and
also in terms of thalamic blood flow.